Brief: Schott Pharma Reports FY 2025 Revenue Of EUR 986.2 Mln
Dec 4 (Reuters) - SCHOTT Pharma AG & Co KgaA 1SXP.DE: EQS-NEWS: SCHOTT PHARMA’S PRELIMINARY RESULTS FOR FISCAL YEAR 2025; OUTLOOK FOR FY 2026 AND UPDATE OF MID-TERM GUIDANCE SCHOTT PHARMA AG & CO KGAA - REPORTS FY 2025 REVENUE OF EUR 986.2M Source text: ID:nEQ7Yg4Bpa Further company coverage: 1SXP.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SCHOTT Pharma AG & Co. KGaA
See all newsEurope Research Roundup: GSK, Schott Pharma, Vodafone
SCHOTT Pharma rises after J.P. Morgan initiates with 'Overweight'
Schott Pharma rises after Barclays upgrades to 'overweight' on accelerating growth outlook
Europe Research Roundup: Adyen, GYM Group, Rolls Royce
Brief: Schott Pharma - Confirms Recently Increased 2026 Financial Year Guidance